---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "Reanimo – Erste Hilfe & CPR"
developer_entity: "Christopher Kolodzeycik"
bundle_id: "com.redmanlabs.reanimo"
app_store_id: "6806015474"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Freemium"
offline_capable: false
market_region: "US"
platforms: "iOS"
app_last_updated: "2026-10-05"
report_date: "2026-10-05"
last_verified: "2026-10-05T00:00:00.000Z"
report_version: "1.3"
total_reviews: 0
confidence: "low"
confidence_score: 0.2
data_age_days: 46
momentum_velocity: "active"
intelligence_version: 2
tags: ["medical", "freemium", "mobile app", "app review", "app analysis", "individuals", "seeking", "accessible,"]
canonical_url: "https://marlvel.ai/apps/reanimo-erste-hilfe-cpr"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---

# Reanimo – Erste Hilfe & CPR Intelligence Report

## TL;DR {#tldr}

- **Category**: Medical · Freemium

> **TL;DR:** Reanimo – Erste Hilfe & CPR is a medical app by Christopher Kolodzeycik, available on iOS.
>
> **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** Reanimo – Erste Hilfe & CPR is a medical app by Christopher Kolodzeycik.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Category** | Medical |
| **Developer** | Christopher Kolodzeycik |
| **Pricing** | Freemium |
| **Platforms** | iOS |
| **Confidence** | Low (0.2/1.0) |
| **Data Age** | 46d |

## Metadata & Market Performance
- **Publisher:** Christopher Kolodzeycik
- **Category:** Medical
- **Target Audience:** Individuals seeking accessible, step-by-step CPR guidance and emergency preparedness tools for home or public use.
- **Platforms:** iOS
- **Version Reviewed:** 1.3
- **Report Date:** 2026-10-05
- **Signal Count:** 0 reviews analyzed
- **Confidence:** Low (0.2/1.0)
- **App Store ID (iOS):** 6806015474
- **Bundle ID:** com.redmanlabs.reanimo
- **Data Window:** Analysis based on signals collected up to 2026-10-05

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** Reanimo is a medical guidance app for CPR and first aid, providing step-by-step emergency flows and a haptic metronome on iOS and Apple Watch.
**Why users hire it:** It removes the cognitive friction of manual rhythm counting and decision-making during high-stress medical emergencies, where every second impacts survival probability.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Standard] Guided Emergency Flow:** Step-by-step decision tree for CPR and recovery position.
  * *User Intent:* Users need clear guidance to understand and adopt the product quickly.
- **[Differentiator] Metronome:** Visual and haptic cues for 100-120 compressions per minute.
- **[Differentiator] AED Map:** Interactive locator for nearby defibrillators.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

Reanimo serves the Medical category with a focus on localized European resuscitation protocols. Its freemium model gates advanced safety tools, positioning it as a utility-first app rather than a broad-market health tracker.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Freemium
- **Tiers:** Free core emergency features, Pro version via one-time purchase
- **Analysis:** Core life-saving features remain free and ad-free to build trust, while advanced tools like AED mapping and infant protocols are gated behind a one-time purchase.

<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Haptic metronome integration on Apple Watch enforces CPR rhythm

**Growth Levers:**
- Expansion of AED map database into high-traffic urban centers


<!-- /section:swot -->
<!-- section:whats-new -->
## What's New

- **Latest (v1.3, today):** Expanded AED map functionality to support panning and zooming, introduced a bottom tab bar for navigation, and improved Reanimo Pro discoverability.
<!-- /section:whats-new -->

<!-- section:momentum -->
## App Momentum (Active) {#momentum}

- Shipped AED map functionality.
- Added bottom tab navigation.
- Maintains active monthly update cadence.

> **Cadence:** 2 total versions · 1 majors in last 6 months · 0 days since last update · 22 days avg between updates

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

Reanimo – Erste Hilfe & CPR is a medical app that is free with in-app purchases.

<!-- speakable-start -->
> **Bottom Line:** Reanimo provides a reliable, haptic-enabled CPR tool that excels in its niche, but the current regional guideline restriction limits its global utility. Addressing this protocol gap would unlock the app's potential for a wider international user base.
<!-- speakable-end -->

**Best for:** Individuals seeking accessible, step-by-step CPR guidance and emergency preparedness tools for home or public use.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [INVEST] Ship regional protocol support because current European-only guidelines limit addressable market size → increase total addressable market
<!-- /section:pm-actions -->

<!-- section:outlook -->
### Outlook: Stable

The emergency preparedness category is consolidating around apps that offer hardware-integrated, low-friction guidance. Reanimo is well-positioned in its home market, but its future growth depends on its ability to adapt to non-European resuscitation standards.

- 🟢 The latest release added AED map panning and zooming, showing active feature investment rather than maintenance-only updates.
- ⚪ The app's reliance on European Resuscitation Council guidelines creates a growth ceiling that requires a clear regional expansion roadmap to overcome.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Total Reviews | 0 |
| Confidence | Low |
| Pricing Model | Freemium |
| Platforms | iOS |
| Key Features | 3 analyzed |
| Outlook | Stable |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **Reanimo – Erste Hilfe & CPR** (this app) | N/A/5 | N/A | Christopher Kolodzeycik |
| [Lace Pro](https://marlvel.ai/apps/lace-pro) | 4.6/5 | Excited | Neurotone AI |
| [VetCore: Pet Health Records](https://marlvel.ai/apps/vetcore-pet-health-records) | N/A/5 | N/A | Dmitriy Motorin |
| [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo |
| [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. |
| [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase |

## Company Profile
- **Developer:** Christopher Kolodzeycik
- **Website:** [https://redmanlabs.web.app](https://redmanlabs.web.app)

## Data Sources & Links
- **App Store ID:** 6806015474
- **Dev Site:** [Official Website](https://redmanlabs.web.app)
- **Sources:** Developer website content, App store metadata.

## Related Intel Reports
- [*Lace Pro*](https://marlvel.ai/apps/lace-pro) (Neurotone AI) · 4.6/5 Rating | Positive Sentiment
- [*VetCore: Pet Health Records*](https://marlvel.ai/apps/vetcore-pet-health-records) (Dmitriy Motorin) · N/A Rating
- [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating
- [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating
- [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating
- [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating
- [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor  Ltd. Şti.) · 4.8/5 Rating
- [*101 Last Minute Study Tips*](https://marlvel.ai/apps/101-last-minute-study-tips) (Limmer Creative) · 3.4/5 Rating
- [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating
- [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes).
4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.2/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 0
- **Data Sources:** developer website, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 46 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/reanimo-erste-hilfe-cpr)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.